Expression and purification of the α-subunit of eukaryotic initiation factor eIF2: Use as a kinase substrate

Protein Expression and Purification

Volumn 12, Issue 3, 1998, Pages 415-419

  Kimball, Scot R ^a   Horetsky, Rick L ^a   Jagus, Rosemary ^b   Jefferson, Leonard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; INITIATION FACTOR; MESSENGER RNA; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RNA TRANSLATION;

EUKARYOTA; UNIDENTIFIED BACULOVIRUS;

EID: 0032052990     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1998.0863     Document Type: Article

References (14)

1. Pain V. M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236:1996;747-771.
2. Clemens M. J. Protein kinases that phosphorylate eIF2 and eIF2B, and their role in eukaryotic cell translational control. Translational Control. 1996;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 139-172.
3. Samuel C. E., Kuhen K. L., George C. X., Ortega L. G., Rendefournier R., Tanaka H. The PKR protein kinase - An interferon-inducible regulator of cell growth and differentiation. Intl. J. Hematol. 65:1997;227-237.
4. Samuel C. E. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeast to humans. J. Biol. Chem. 268:1993;7603-7606.
5. Redpath N. T., Proud C. G. Molecular mechanisms in the control of translation by hormones and growth factors. Biochem. Biophys. Acta. 1220:1994;147-162.
6. Proud C. G. PKR: A new name and new roles. Trends Biochem. Sci. 20:1995;241-246.
7. Jackson R. J., Hunt T. A novel approach to the isolation of rabbit reticulocyte haem-controlled eIF2α protein kinase. Biochem. Biophys. Acta. 826:1985;224-228.
8. Barber G. N., Tomita J., Hovanessian A. G., Meurs E., Katze M. G. Functional expression and characterization of the interferon-induced double-stranded RNA-activated P68 protein kinase inE. coli. Biochemistry. 30:1991;10356-10361.
9. Barber G. N., Jagus R., Meurs E. F., Hovananessian A. G., Katze M. G. Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270:1995;17423-17428.
10. Kimball S. R., Jefferson L. S. Mechanism of inhibition of peptide chain initiation by amino acid deprivation in perfused rat liver: Regulation involving inhibition of eukaryotic initiation factor 2α phosphatase activity. J. Biol. Chem. 266:1991;1969-1976.
11. Carroll K., Elroy-Stein O., Moss B., Jagus R. Recombinant Vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2α-specific protein kinase. J. Biol. Chem. 268:1993;12837-12842.
12. Dever T. E., Feng L., Wek R. C., Cigan A. M., Donahue T. F., Hinnebusch A. G. Phosphorylation of initiation factor 2α by protein kinase GCN2 mediates gene-specific translational control ofGCN4. Cell. 68:1992;585-596.
13. Kimball S. R., Everson W. V., Myers L. M., Jefferson L. S. Purification and characterization of eukaryotic initiation factor 2 and a guanine nucleotide exchange factor from rat liver. J. Biol. Chem. 262:1987;2220-2227.
14. Mellor H., Proud C. G. A synthetic peptide substrate for initiation factor-2 kinases. Biochem. Biophys. Res. Commun. 178:1991;430-437.